Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Regioselective Nucleophilic Aromatic Substitution (SNAr). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112088003A details a regioselective route for LRRK2 inhibitors. Offers scalable synthesis, improved purity, and cost-effective manufacturing for pharmaceutical intermediates.